EUVIMEDEUVIMED entdecken
Crossref

Neomycin-induced deafness in neonatal mice

Raffaello M Cutri, Joshua Lin, Nhi V Nguyen, Dejan Shakya, Seiji B Shibata

Journal of Neuroscience Methods · 2023

DOI: 10.1016/j.jneumeth.2023.109852 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroscience Methods, 2023. Verfasst von Raffaello M Cutri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Keck School of Medicine of University of Southern California, Los Angeles, CA 90033, USA. Hauptthemen laut MEDLINE: Neomycin, Deafness. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: NIDCD NIH HHS, American Otological Society Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Hearing impairment is a rising public health issue, and current therapeutics fail to restore normal auditory sensation. Animal models are essential to a better understanding of the pathophysiology of deafness and developing therapeutics to restore hearing. NEW METHODS: Wild-type CBA/CaJ neonatal mice P2-5 were used in this study. Neomycin suspension (500 nl of 50 or 100 mg/ml) was micro-injected into the endolymphatic space. Cochlear morphology was examined 3 and 7 days after injection; hair cell (HC) loss, supporting cell morphology, and neurite denervation pattern were assessed with whole-mounts. At 2 and 4 weeks post-injection, the spiral ganglion neuron (SGN) density was analyzed with cryostat sections. Audiometric responses were measured with auditory brain response (ABR) at 4 weeks. RESULTS: Rapid and complete degeneration of the inner and outer HCs occurred as early as 3 days post-injection. Subsequently, time- and dose-dependent degeneration patterns were observed along the axis of the cochlear membranous labyrinth forming a flat epithelium. Likewise, the SGN histology demonstrated significant cell density reduction at 2 and 4 weeks. The ABR threshold measurements confirmed profound deafness at 4 weeks. COMPARISON WITH EXISTING METHODS: Compared to previously described local and systemic aminoglycoside injections, this method provides a reliable, robust, and rapid deafening model with a single infusion of neomycin in neonatal mice. This model also allows for investigating the effects of inner ear damage during auditory maturation. CONCLUSIONS: A single injection of neomycin into the endolymphatic space induces robust HC loss and denervation in neonatal mice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeomycinDeafnessAnimalsMiceAnimals, NewbornMice, Inbred CBACochleaSpiral GanglionEvoked Potentials, Auditory, Brain Stem

Stichwörter der Autor:innen

AminoglycosidesHair cellsHearing lossNeomycinSpiral ganglion cells

Substanzen

Neomycin

Autor:innen und Institutionen

  • Keck School of Medicine of University of Southern California, Los Angeles, CA 90033, USA.
  • Caruso Department of Otolaryngology-Head and Neck Surgery, University of Southern California, Los Angeles, CA 90033, USA.
  • Dornsife College of Letters, Arts, and Sciences, University of Southern California, Los Angeles, CA 90089, USA.
  • Caruso Department of Otolaryngology-Head and Neck Surgery, University of Southern California, Los Angeles, CA 90033, USA. Electronic address: Seiji.Shibata@med.usc.edu.

Förderung

  • NIDCD NIH HHS
  • American Otological Society Inc

Zitieren

APA

Cutri, R. M., Lin, J., Nguyen, N. V., Shakya, D., & Shibata, S. B. (2023). Neomycin-induced deafness in neonatal mice. Journal of Neuroscience Methods. https://doi.org/10.1016/j.jneumeth.2023.109852

Vancouver

Cutri RM, Lin J, Nguyen NV, Shakya D, Shibata SB. Neomycin-induced deafness in neonatal mice. Journal of Neuroscience Methods. 2023. doi:10.1016/j.jneumeth.2023.109852

BibTeX
@article{Cutri2023,
  author = {Cutri, Raffaello M and Lin, Joshua and Nguyen, Nhi V and Shakya, Dejan and Shibata, Seiji B},
  title = {Neomycin-induced deafness in neonatal mice},
  journal = {Journal of Neuroscience Methods},
  year = {2023},
  doi = {10.1016/j.jneumeth.2023.109852}
}
Kostenlos starten →